-
公开(公告)号:US07879852B2
公开(公告)日:2011-02-01
申请号:US12305935
申请日:2007-07-13
Applicant: Sung Pil Choi , In Ae Ahn , Sang Hyup Lee , Sang Dae Lee , Mi Sook Shin , Koo Lee , Deog Young Choi , Dong Sup Shim , Hyeon Joo Yim , Min Kyung Yoon , Soo Yong Chung , Jung Ae Lee , Yong Hwa Ha , Young Kwan Kim , Oeuk Park , Hyun Min Lee , Youn Hoa Kim
Inventor: Sung Pil Choi , In Ae Ahn , Sang Hyup Lee , Sang Dae Lee , Mi Sook Shin , Koo Lee , Deog Young Choi , Dong Sup Shim , Hyeon Joo Yim , Min Kyung Yoon , Soo Yong Chung , Jung Ae Lee , Yong Hwa Ha , Young Kwan Kim , Oeuk Park , Hyun Min Lee , Youn Hoa Kim
IPC: A61K31/401 , A61K31/4025 , A61K31/422 , A61K31/427 , A61K31/4439 , A61K31/5377 , C07D207/14 , C07D213/72 , C07D263/48 , C07D277/54 , C07D295/28
CPC classification number: C07D207/16 , C07D207/48 , C07D401/14 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/14
Abstract: The present invention relates to a compound of the following formula 1, pharmaceutically acceptable salt and isomer thereof effective as agonist of melanocortin receptor, and an agonistic composition of melanocortin receptor comprising the same as active ingredient.
Abstract translation: 本发明涉及有效作为黑皮质素受体激动剂的下式1化合物,其药学上可接受的盐和异构体,以及包含与活性成分相同的黑皮质素受体激动剂组合物。
-
公开(公告)号:US20090298829A1
公开(公告)日:2009-12-03
申请号:US12305935
申请日:2007-07-13
Applicant: Sung Pil Choi , In Ae Ahn , Sang Hyup Lee , Sang Dae Lee , Mi Sook Shin , Koo Lee , Deog Young Choi , Dong Sup Shim , Hyeon Joo Yim , Min Kyung Yoon , Soo Yong Chung , Jung Ae Lee , Yong Hwa Ha , Young Kwan Kim , Oeuk Park , Hyun Min Lee , Youn Hoa Kim
Inventor: Sung Pil Choi , In Ae Ahn , Sang Hyup Lee , Sang Dae Lee , Mi Sook Shin , Koo Lee , Deog Young Choi , Dong Sup Shim , Hyeon Joo Yim , Min Kyung Yoon , Soo Yong Chung , Jung Ae Lee , Yong Hwa Ha , Young Kwan Kim , Oeuk Park , Hyun Min Lee , Youn Hoa Kim
IPC: A61K31/4025 , C07D401/06 , C07D413/14 , A61K31/5377 , A61P3/04 , A61P3/10 , A61P29/00 , A61P15/00
CPC classification number: C07D207/16 , C07D207/48 , C07D401/14 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/14
Abstract: The present invention relates to a compound of the following formula 1, pharmaceutically acceptable salt and isomer thereof effective as agonist of melanocortin receptor, and an agonistic composition of melanocortin receptor comprising the same as active ingredient.
Abstract translation: 本发明涉及有效作为黑皮质素受体激动剂的下式1化合物,其药学上可接受的盐和异构体,以及包含与活性成分相同的黑皮质素受体激动剂组合物。
-